من السياسات الحياتية إلى السياسات الحياتية الجزيئية و المواطنة البيولوجية

Abstract EN

Molecular transformation (molecularization) has become central to contemporary biology thinking, and thus to contemporary biomedical practices and policies.

Today, biomedical technologies operate not only to treat diseases but also to manage, alter, engineer, reshape, enhance, maximize and predict vital processes of both body and mind at the molecular level.

If the biopolitics was centered around the "molar" level of the population, bodies and organs, then biomedicine now realizes life at the "molecular" level, that is, at the level of genetic materials (DNA and its component).

The result is a wide-ranging shift away from the modern biopolitics - from managing risk at the population level to managing individual genetic risks - with critical implications on governmentality, subjectivity and ethics.

In today's contemporary formations, race, health, genealogy, and reproduction are intertwined at the micro level, which necessarily affects the formation of new life-centered subjectivity, sociality, and citizenship This research focuses on studying the transition from biopolitics to molecular biopolitics, where life itself is divided into molecules and this marks the beginning of a new era by changing the prevailing models of state practices, human health, subjectivity, and identity.